Bukkuri, Anuraag
Pienta, Kenneth J.
Austin, Robert H.
Hammarlund, Emma U.
Amend, Sarah R.
Brown, Joel S.
Article History
Received: 31 January 2023
Accepted: 9 September 2023
First Online: 12 September 2023
Competing interests
: KJP is a consultant for CUE Biopharma, Inc., and holds equity interest in CUE Biopharma, Inc., Keystone Biopharma, Inc. and PEEL Therapeutics, Inc. SRA holds equity interest in Keystone Biopharma, Inc. AB, RHA, EUH, and JSB declare no potential conflict of interest.